A promising anti-ageing drug is about to undergo human trials for the first time

Can we really hope to slow down the ageing process? The compound nicotinamide mononucleotide (NMN) has shown plenty of promise at increasing the lifespans of mice, and is about to be put to the test in human clinical trials for the first time.

Continue reading…

Like what you read? Give Snapzu Science a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.